Both manufacturing process records and sterilization process records have been reviewed and no discrepancies were found in the manufacturing file of this batch of access ports lal and sterility test results were within specifications.No other complaint has been reported to us on this batch of access ports released in march 2016.In addition, the bacteria "burkholderia cepacia" at the origin of the infection has never been identified on one of our products.As this complaint is an isolated case and as the infection does not seems to be imputable to the device, no corrective action is envisaged.
|
"the patient was a female and a breast cancer patient.Chemoport was inserted under aspectic conditions.However, before they could access for chemotherapy, the patient started having fever with chills and investigations revealed primary port infection.The blood culture from the port showed growth of "burkholderia cepacia." the port had to be removed.".
|